BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

620 related articles for article (PubMed ID: 20159561)

  • 21. Leukemogenesis via aberrant self-renewal by the MLL/AEP-mediated transcriptional activation system.
    Yokoyama A
    Cancer Sci; 2021 Oct; 112(10):3935-3944. PubMed ID: 34251718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting Processive Transcription Elongation via SEC Disruption for MYC-Induced Cancer Therapy.
    Liang K; Smith ER; Aoi Y; Stoltz KL; Katagi H; Woodfin AR; Rendleman EJ; Marshall SA; Murray DC; Wang L; Ozark PA; Mishra RK; Hashizume R; Schiltz GE; Shilatifard A
    Cell; 2018 Oct; 175(3):766-779.e17. PubMed ID: 30340042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Misguided transcriptional elongation causes mixed lineage leukemia.
    Mueller D; García-Cuéllar MP; Bach C; Buhl S; Maethner E; Slany RK
    PLoS Biol; 2009 Nov; 7(11):e1000249. PubMed ID: 19956800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The molecular biology of mixed lineage leukemia.
    Slany RK
    Haematologica; 2009 Jul; 94(7):984-93. PubMed ID: 19535349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complex three-way translocation involving MLL, ELL, RREB1, and CMAHP genes in an infant with acute myeloid leukemia and t(6;19;11)(p22.2;p13.1;q23.3).
    Tuborgh A; Meyer C; Marschalek R; Preiss B; Hasle H; Kjeldsen E
    Cytogenet Genome Res; 2013; 141(1):7-15. PubMed ID: 23735562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of transcriptional regulation by MLL and its disruption in acute leukemia.
    Dou Y; Hess JL
    Int J Hematol; 2008 Jan; 87(1):10-8. PubMed ID: 18224408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The E3 ubiquitin ligase Triad1 influences development of Mll-Ell-induced acute myeloid leukemia.
    Wang H; Bei L; Shah CA; Huang W; Platanias LC; Eklund EA
    Oncogene; 2018 May; 37(19):2532-2544. PubMed ID: 29459712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure of the super-elongation complex subunit AFF4 C-terminal homology domain reveals requirements for AFF homo- and heterodimerization.
    Chen Y; Cramer P
    J Biol Chem; 2019 Jul; 294(27):10663-10673. PubMed ID: 31147444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The mixed-lineage leukemia fusion partner AF4 stimulates RNA polymerase II transcriptional elongation and mediates coordinated chromatin remodeling.
    Bitoun E; Oliver PL; Davies KE
    Hum Mol Genet; 2007 Jan; 16(1):92-106. PubMed ID: 17135274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV-1 Tat and host AFF4 recruit two transcription elongation factors into a bifunctional complex for coordinated activation of HIV-1 transcription.
    He N; Liu M; Hsu J; Xue Y; Chou S; Burlingame A; Krogan NJ; Alber T; Zhou Q
    Mol Cell; 2010 May; 38(3):428-38. PubMed ID: 20471948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A translocation in acute lymphoblastic leukemia that cytogenetically mimics the recurrent MLL-AFF1 translocation and fuses SEPT11 to MLL.
    Stevens SJ; Meers LE; Albrechts JC; Mebis-Verhees K; Bos GM; Engelen JJ; Janssen JW
    Cancer Genet Cytogenet; 2010 Aug; 201(1):48-51. PubMed ID: 20633769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Crosstalk between 14-3-3θ and AF4 enhances MLL-AF4 activity and promotes leukemia cell proliferation.
    Fioretti T; Cevenini A; Zanobio M; Raia M; Sarnataro D; Salvatore F; Esposito G
    Cell Oncol (Dordr); 2019 Dec; 42(6):829-845. PubMed ID: 31493143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A role for the MLL fusion partner ENL in transcriptional elongation and chromatin modification.
    Mueller D; Bach C; Zeisig D; Garcia-Cuellar MP; Monroe S; Sreekumar A; Zhou R; Nesvizhskii A; Chinnaiyan A; Hess JL; Slany RK
    Blood; 2007 Dec; 110(13):4445-54. PubMed ID: 17855633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An RNA polymerase II elongation factor encoded by the human ELL gene.
    Shilatifard A; Lane WS; Jackson KW; Conaway RC; Conaway JW
    Science; 1996 Mar; 271(5257):1873-6. PubMed ID: 8596958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular analysis of t(11;19) breakpoints in childhood acute leukemias.
    Rubnitz JE; Behm FG; Curcio-Brint AM; Pinheiro RP; Carroll AJ; Raimondi SC; Shurtleff SA; Downing JR
    Blood; 1996 Jun; 87(11):4804-8. PubMed ID: 8639852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure and function of RNA polymerase II elongation factor ELL. Identification of two overlapping ELL functional domains that govern its interaction with polymerase and the ternary elongation complex.
    Shilatifard A; Haque D; Conaway RC; Conaway JW
    J Biol Chem; 1997 Aug; 272(35):22355-63. PubMed ID: 9268387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel variant form of MLL-ELL fusion transcript with t(11;19)(q23;p13.1) in chronic myelomonocytic leukemia transforming to acute myeloid leukemia.
    Kakihana K; Kubo F; Wakabayashi S; Kurosu T; Miki T; Murakami N; Miura O
    Cancer Genet Cytogenet; 2008 Jul; 184(2):109-12. PubMed ID: 18617060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular pathogenesis of MLL-associated leukemias.
    Eguchi M; Eguchi-Ishimae M; Greaves M
    Int J Hematol; 2005 Jul; 82(1):9-20. PubMed ID: 16105754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AF4 and AF4-MLL mediate transcriptional elongation of 5-lipoxygenase mRNA by 1, 25-dihydroxyvitamin D3.
    Ahmad K; Scholz B; Capelo R; Schweighöfer I; Kahnt AS; Marschalek R; Steinhilber D
    Oncotarget; 2015 Sep; 6(28):25784-800. PubMed ID: 26329759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ELL and EAF1 are Cajal body components that are disrupted in MLL-ELL leukemia.
    Polak PE; Simone F; Kaberlein JJ; Luo RT; Thirman MJ
    Mol Biol Cell; 2003 Apr; 14(4):1517-28. PubMed ID: 12686606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.